Gamma Medica-Ideas, a Northridge developer of medical imaging systems, said that it has raised $24 million in financing from three funders.

The financing announced this week was comprised of $14 million in equity capital from the Psilos Group and Capital Resource Partners; $5 million in mezzanine debt from Capital Resource; and a $5 million revolving line of credit from Bridge Bank.

Lead by founder and chief executive Bradley E. Patt, the company’s initial product for humans is the LumaGEM, a digital imager that aims to improve diagnosis of cancers in women with dense breast tissue and has U.S. Food and Drug Administration device clearance. Its small animal imaging products are distributed by GE Healthcare globally and by a Seiko company in Japan.

“LumaGEM has the ability to diagnose breast cancers with accuracy rivaling that of MRI but at one-third the cost,” David Eichler, managing member of Psilos Group, said in a statement. “This is exactly the type of opportunity that Psilos believes is best positioned for success in the new healthcare economy.”